[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-343872-105":3,"detail-sidebar-cat-0-en-105":80,"doc-detail-343872-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":73,"head_meta":75,"extra_data":77,"updated_unix":79},105,"en","sam-dnmt3a-a-strategy-for-induction-of-genome-wide-dna-methylation-identifies-dna-methylation-as-a-vulnerability-in-er-positive-breast-cancers","SAM-DNMT3A, a strategy for induction of genome-wide DNA methylation, identifies DNA methylation as a vulnerability in ER-positive breast cancers","","Engineered SAM-DNMT3A enables induction of DNA methylation using a CRISPR-based synergistic activation mediator strategy. Despite targeting sequence differences, any sgRNA triggers global genome-wide DNA methylation, creating a method that supports study of whole-genome methylation. The work positions induced global methylation as a distinctive vulnerability in ER-positive breast cancers, suggesting a potential therapeutic angle. Findings also emphasize caution when CRISPR approaches are used to induce methylation.",{"@graph":14,"@context":72},[15,34,55],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/sam-dnmt3a-a-strategy-for-induction-of-genome-wide-dna-methylation-identifies-dna-methylation-as-a-vulnerability-in-er-positive-breast-cancers/343872/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/sam-dnmt3a-a-strategy-for-induction-of-genome-wide-dna-methylation-identifies-dna-methylation-as-a-vulnerability-in-er-positive-breast-cancers/343872.png","ImageObject",300,407,{"name":42,"@type":43},"Quinn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-25","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":33},"InteractionCounter",{"@type":54},"ViewAction",{"@type":56,"mainEntity":57},"FAQPage",[58,64,68],{"name":59,"@type":60,"acceptedAnswer":61},"What problem does the study address about DNA methylation research?","Question",{"text":62,"@type":63},"A key limitation is the lack of tools that can induce global genome-wide DNA methylation for functional studies.","Answer",{"name":65,"@type":60,"acceptedAnswer":66},"How does SAM-DNMT3A induce DNA methylation in the genome?",{"text":67,"@type":63},"Using a CRISPR-based SAM system, the approach unexpectedly produces global genome-wide DNA methylation regardless of the targeted sequence and sgRNA used.",{"name":69,"@type":60,"acceptedAnswer":70},"Why is DNA methylation induction relevant to ER-positive breast cancer?",{"text":71,"@type":63},"Induction of global DNA methylation is identified as a unique vulnerability in ER-positive breast cancer, supporting a potential therapeutic strategy.","https://schema.org",{"og:url":32,"og:type":74,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":76,"canonical":32},"index,follow",{"doc_id":78,"site_id":7},343872,1790822098,{"code":4,"msg":81,"data":82},"success",[83,87,91,95,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":84,"show_sort_weight":85,"slug":86},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":88,"show_sort_weight":89,"slug":90},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":92,"show_sort_weight":93,"slug":94},"Exam",70,"exam",{"id":96,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},5,"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":96,"slug":129},19,"General","general",{"code":4,"msg":81,"data":131},{"doc_id":78,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":33,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":112,"preview_page_count":33,"preview_urls":145},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Article [https://doi.org/10.1038/s41467-024-54824-8](https://doi.org/10.1038/s41467-024-54824-8)  \nSAM-DNMT3A, a strategy for induction of genome-wide DNA methylation, identiﬁes DNA methylation as a vulnerability in ER-positive breast cancers  \nReceived: 8 January 2024  \n\n| Accepted: 20 November 2024 |\n| --- |\n| |\n| Check for updates |\n\nMahnaz Hosseinpour 1,2,3, Xinqi Xi1, Ling Liu 1, Luis Malaver-Ortega4,  \nLaura Perlaza-Jimenez1, Jihoon E. Joo3, Harrison M. York 5, Jonathan Beesley6, C. Elizabeth Caldon 7, Pierre-Antoine Dugué 2,8,9, James G. Dowty 9, Senthil Arumugam 5,10, Melissa C. Southey 2,3,8  & Joseph Rosenbluh 1,4   \nDNA methylation is an epigenetic mark that plays a critical role in regulating gene expression. DNA methyltransferase (DNMT) inhibitors, inhibit global DNA methylation and have been a key tool in studies of DNA methylation. A major bottleneck is the lack of tools to induce global DNA methylation. Here, we engineered a CRISPR based approach, that we initially designed, to enable site-speciﬁc DNA methylation. Using the synergistic activation mediator (SAM) system, we unexpectedly ﬁnd that regardless of the targeted sequence any sgRNA induces global genome-wide DNA methylation. We term this method SAM-DNMT3A and show that induction of global DNA methylation is a unique vulnerability in ER-positive breast cancer suggesting a therapeutic approach. Our ﬁndings highlight the need of caution when using CRISPR based approaches for inducing DNA methylation and demonstrate a method for global induction of DNA methylation.  \nDNA methylation is a reversible epigenetic modiﬁcation that plays an important role in regulating gene expression and maintaining the stability of the genome1. DNA methylation at promoters regulates gene expression by preventing transcription factors from binding to DNA and initiating transcription2. In contrast, DNA methylation at gene body regions can have complex effects on gene expression, sometimes enhancing it3–5. Aberrant DNA methylation patterns have been associated with a wide range of diseases, including cancer, neurological disorders, and developmental disorders1. Mendelian-like inheritance  \nof DNA methylation has been shown in various organisms6. We have shown that in some cases heritable DNA methylation is associated with susceptibility to different cancer types7–9. Although DNA methylationis a fundamental cellular process that is involved in almost every aspect of life, due to the limited available toolkit to study DNA methylation, we still lack comprehensive understanding of how DNA methylation mediates biological processes.  \nDNA methylation is induced by DNA methyltransferases (DNMT’s) that in humans include DNMT3A and DNMT3B and is maintained by  \n1Department of Biochemistry and Molecular Biology and Cancer program, Biomedicine Discovery Institute, Monash University, Melbourne, VIC, Australia. 2Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, VIC, Australia. 3Department of Clinical Pathology, Melbourne Medical School, The University of Melbourne, Melbourne, VIC, Australia. 4Functional Genomics Platform, Monash University, Melbourne, VIC, Australia. 5Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute, Monash University, Melbourne, VIC, Australia. 6Cancer Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. 7The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, NSW, Australia. 8Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia. 9Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia. 10EMBL Australia, Monash University, Melbourne, VIC, Australia. [e-mail:](e-mail: melissa.southey@monash.edu)[ melissa.southey@monash.edu](e-mail: melissa.southey@monash.edu); seﬁ.[rosenbluh@monash.edu](rosenbluh@monash.edu)  \nDNMT110. The DNA methylation ma","cbCaihWK11IdiaAB","https://ap.wps.com/l/cbCaihWK11IdiaAB","pdf",3707935,12,"English","# Introduction\n## DNA methylation and existing tools\n## CRISPR-based induction approaches\n# Results\n## Development of SAM-DNMT3A\n## Global induction via SAM system\n# Implications","[{\"question\":\"What problem does the study address about DNA methylation research?\",\"answer\":\"A key limitation is the lack of tools that can induce global genome-wide DNA methylation for functional studies.\"},{\"question\":\"How does SAM-DNMT3A induce DNA methylation in the genome?\",\"answer\":\"Using a CRISPR-based SAM system, the approach unexpectedly produces global genome-wide DNA methylation regardless of the targeted sequence and sgRNA used.\"},{\"question\":\"Why is DNA methylation induction relevant to ER-positive breast cancer?\",\"answer\":\"Induction of global DNA methylation is identified as a unique vulnerability in ER-positive breast cancer, supporting a potential therapeutic strategy.\"}]","SAM-DNMT3A, a strategy for induction of genome-wide DNA methylation, identifies DNA methylation as a vulnerability in ER-positive breast cancers | PDF",1790052351,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e15b9cd20343592d588a5b9d037e2de0.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/76119b4bbf59d3bd8ca9cc860c6e4f29.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e683fce1b81770d6c9eab4a74eb0c28c.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2207d2944505cde8bd80dab24899390c.webp",980,1301]